UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPP
2101
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
| $8.52M | ﹤0.01% |
524,619
-43,950
| -8% | -$733K |
|
|
HSBC.PRA
2102
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $8.51M | ﹤0.01% |
316,607
-125,446
| -28% | -$3.31M |
|
2103
ACI Worldwide
ACIW
$5.62B
| $8.51M | ﹤0.01% |
224,602
+137,544
| +158% | +$4.69M |
|
2104
BJs Wholesale Club
BJ
$12.3B
| $8.5M | ﹤0.01% |
373,890
+276,035
| +282% | +$6.82M |
|
|
ATH
2105
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $8.5M | ﹤0.01% |
180,691
-88,731
| -33% | -$3.86M |
|
2106
CALL
Alcon
ALC
$33.9B
| $8.49M | ﹤0.01% |
150,000
-34,300
| -19% | -$1.96M |
|
2107
Edgewell Personal Care
EPC
$1.3B
| $8.48M | ﹤0.01% |
274,056
+106,169
| +63% | +$3.43M |
|
2108
BlackRock Enhanced Global Dividend Trust
BOE
$681M
| $8.47M | ﹤0.01% |
770,826
+11,357
| +1% | +$121K |
|
2109
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.95B
| $8.42M | ﹤0.01% |
377,632
-68,538
| -15% | -$1.45M |
|
2110
Sabre
SABR
$846M
| $8.42M | ﹤0.01% |
375,232
+264,663
| +239% | +$5.87M |
|
2111
First Trust RiverFront Dynamic Developed International ETF
RFDI
$166M
| $8.41M | ﹤0.01% |
140,279
-18,534
| -12% | -$1.07M |
|
2112
MillerKnoll
MLKN
$1.62B
| $8.39M | ﹤0.01% |
201,536
+68,965
| +52% | +$3.19M |
|
2113
PUT
Marriott International
MAR
$93.4B
| $8.39M | ﹤0.01% |
55,400
-100
| -0.2% | -$13.4K |
|
2114
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$249M
| $8.37M | ﹤0.01% |
436,816
-3,565
| -0.8% | -$66.1K |
|
2115
NIO
NIO
$11.4B
| $8.36M | ﹤0.01% |
2,078,390
-128,544
| -6% | -$258K |
|
2116
World Kinect Corp
WKC
$1.92B
| $8.35M | ﹤0.01% |
192,372
+65,312
| +51% | +$2.73M |
|
2117
CubeSmart
CUBE
$9.46B
| $8.35M | ﹤0.01% |
265,148
+69,277
| +35% | +$2.22M |
|
2118
DNP Select Income Fund
DNP
$4.03B
| $8.34M | ﹤0.01% |
653,406
-6,345
| -1% | -$80.8K |
|
|
BRW
2119
Saba Capital Income & Opportunities Fund
BRW
$342M
| $8.34M | ﹤0.01% |
831,880
+73,636
| +10% | +$710K |
|
2120
Southern Copper
SCCO
$162B
| $8.33M | ﹤0.01% |
211,525
+20,810
| +11% | +$725K |
|
2121
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
| $8.32M | ﹤0.01% |
87,500
-97,200
| -53% | -$8.41M |
|
2122
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
| $8.32M | ﹤0.01% |
266,891
+51,947
| +24% | +$1.56M |
|
2123
PUT
ICICI Bank
IBN
$109B
| $8.3M | ﹤0.01% |
550,000
| – | – |
|
2124
NCR Voyix
VYX
$1.2B
| $8.3M | ﹤0.01% |
384,708
+205,175
| +114% | +$3.99M |
|
2125
Federated Hermes
FHI
$4.73B
| $8.29M | ﹤0.01% |
254,337
+117,836
| +86% | +$3.85M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.